Methamphetamine-associated heart failure: a systematic review of observational studies

Author:

Manja VeenaORCID,Nrusimha Ananya,Gao Ya,Sheikh Aleesha,McGovern Mark,Heidenreich Paul A,Sandhu Alex Tarlochan Singh,Asch Steven

Abstract

ObjectiveTo conduct a systematic review of observational studies on methamphetamine-associated heart failure (MethHF) .MethodsSix databases were searched for original publications on the topic. Title/abstract and included full-text publications were reviewed in duplicate. Data extraction and critical appraisal for risk of bias were performed in duplicate.ResultsTwenty-one studies are included in the final analysis. Results could not be combined because of heterogeneity in study design, population, comparator, and outcome assessment. Overall risk of bias is moderate due to the presence of confounders, selection bias and poor matching; overall certainty in the evidence is very low. MethHF is increasing in prevalence, affects diverse racial/ethnic/sociodemographic groups with a male predominance; up to 44% have preserved left-ventricular ejection fraction. MethHF is associated with significant morbidity including worse heart failure symptoms compared with non-methamphetamine related heart failure. Female sex, methamphetamine abstinence and guideline-directed heart failure therapy are associated with improved outcomes. Chamber dimensions on echocardiography and fibrosis on biopsy predict the extent of recovery after abstinence.ConclusionsThe increasing prevalence of MethHF with associated morbidity underscores the urgent need for well designed prospective studies of people who use methamphetamine to accurately assess the epidemiology, clinical features, disease trajectory and outcomes of MethHF. Methamphetamine abstinence is an integral part of MethHF treatment; increased availability of effective non-pharmacological interventions for treatment of methamphetamine addiction is an essential first step. Availability of effective pharmacological treatment for methamphetamine addiction will further support MethHF treatment. Using harm reduction principles in an integrated addiction/HF treatment programme will bolster efforts to stem the increasing tide of MethHF.

Publisher

BMJ

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. A review of the clinical pharmacology of methamphetamine

2. The World Drug Report , 2022. Available: https://www.unodc.org/unodc/en/data-and-analysis/wdr-2021_booklet-4.html2021

3. Global methamphetamine trends:an evolving problem;Stoneberg;Int Crim Justice Rev,2018

4. Hedegaard H , Bastian BA , Trinidad JP , et al . Drugs most frequently involved in drug overdose deaths: United States, 2011-2016, 2018.

5. Characteristics and outcomes of methamphetamine abuse among veterans with heart failure;Nishimura;Am J Cardiol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3